EXOR NV (EXO.AS) Stock Fundamental Analysis

AMS:EXO • NL0012059018

72.35 EUR
+0.65 (+0.91%)
Last: Feb 18, 2026, 05:35 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Overall EXO gets a fundamental rating of 4 out of 10. We evaluated EXO against 58 industry peers in the Financial Services industry. No worries on liquidiy or solvency for EXO as it has an excellent financial health rating, but there are worries on the profitability. EXO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • EXO had negative earnings in the past year.
  • EXO had a positive operating cash flow in the past year.
  • EXO had positive earnings in 4 of the past 5 years.
  • EXO had a positive operating cash flow in each of the past 5 years.
EXO.AS Yearly Net Income VS EBIT VS OCF VS FCFEXO.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

  • With a Return On Assets value of -1.62%, EXO is not doing good in the industry: 79.31% of the companies in the same industry are doing better.
  • EXO has a Return On Equity of -1.78%. This is in the lower half of the industry: EXO underperforms 70.69% of its industry peers.
Industry RankSector Rank
ROA -1.62%
ROE -1.78%
ROIC N/A
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)N/A
ROIC(5y)N/A
EXO.AS Yearly ROA, ROE, ROICEXO.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

  • EXO's Profit Margin has improved in the last couple of years.
  • EXO's Operating Margin has improved in the last couple of years.
  • EXO has a worse Gross Margin (-5096.69%) than 67.24% of its industry peers.
  • EXO's Gross Margin has improved in the last couple of years.
  • EXO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM -5096.69%
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
EXO.AS Yearly Profit, Operating, Gross MarginsEXO.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • EXO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, EXO has less shares outstanding
  • The number of shares outstanding for EXO has been reduced compared to 5 years ago.
  • EXO has a better debt/assets ratio than last year.
EXO.AS Yearly Shares OutstandingEXO.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
EXO.AS Yearly Total Debt VS Total AssetsEXO.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

  • EXO has an Altman-Z score of 3.75. This indicates that EXO is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.75, EXO belongs to the top of the industry, outperforming 81.03% of the companies in the same industry.
  • EXO has a debt to FCF ratio of 1.25. This is a very positive value and a sign of high solvency as it would only need 1.25 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 1.25, EXO belongs to the best of the industry, outperforming 82.76% of the companies in the same industry.
  • A Debt/Equity ratio of 0.08 indicates that EXO is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.08, EXO is doing good in the industry, outperforming 75.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.25
Altman-Z 3.75
ROIC/WACCN/A
WACC4.49%
EXO.AS Yearly LT Debt VS Equity VS FCFEXO.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 2.21 indicates that EXO has no problem at all paying its short term obligations.
  • EXO has a Current ratio of 2.21. This is in the better half of the industry: EXO outperforms 75.86% of its industry peers.
  • EXO has a Quick Ratio of 2.21. This indicates that EXO is financially healthy and has no problem in meeting its short term obligations.
  • EXO has a Quick ratio of 2.21. This is in the better half of the industry: EXO outperforms 77.59% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 2.21
EXO.AS Yearly Current Assets VS Current LiabilitesEXO.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The earnings per share for EXO have decreased strongly by -104.11% in the last year.
  • Measured over the past years, EXO shows a very strong growth in Earnings Per Share. The EPS has been growing by 38.47% on average per year.
  • The Revenue for EXO has decreased by -100.78% in the past year. This is quite bad
  • EXO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -36.03% yearly.
EPS 1Y (TTM)-104.11%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-104.49%
Revenue 1Y (TTM)-100.78%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-103.68%

3.2 Future

  • EXO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -56.74% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-122.68%
EPS Next 2Y-76.12%
EPS Next 3Y-56.74%
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EXO.AS Yearly Revenue VS EstimatesEXO.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B
EXO.AS Yearly EPS VS EstimatesEXO.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • EXO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • EXO is valuated quite expensively with a Price/Forward Earnings ratio of 37.12.
  • Based on the Price/Forward Earnings ratio, EXO is valued a bit more expensive than the industry average as 70.69% of the companies are valued more cheaply.
  • EXO is valuated rather expensively when we compare the Price/Forward Earnings ratio to 28.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 37.12
EXO.AS Price Earnings VS Forward Price EarningsEXO.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, EXO is valued cheaply inside the industry as 86.21% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.35
EV/EBITDA N/A
EXO.AS Per share dataEXO.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • A cheap valuation may be justified as EXO's earnings are expected to decrease with -56.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-76.12%
EPS Next 3Y-56.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.68%, EXO is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.28, EXO has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, EXO's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.68%

5.2 History

  • The dividend of EXO decreases each year by -47.20%.
Dividend Growth(5Y)-47.2%
Div Incr Years2
Div Non Decr Years2
EXO.AS Yearly Dividends per shareEXO.AS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

  • The earnings of EXO are negative and hence is the payout ratio. EXO will probably not be able to sustain this dividend level.
  • EXO's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-14.35%
EPS Next 2Y-76.12%
EPS Next 3Y-56.74%
EXO.AS Yearly Income VS Free CF VS DividendEXO.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

More info and screens

Find the best dividend stocksShow peers with best dividend

EXOR NV

AMS:EXO (2/18/2026, 5:35:15 PM)

72.35

+0.65 (+0.91%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)09-17
Earnings (Next)03-23
Inst Owners28.28%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap15.03B
Revenue(TTM)-302.00M
Net Income(TTM)-648.00M
Analysts86.15
Price Target117.43 (62.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.68%
Yearly Dividend0.46
Dividend Growth(5Y)-47.2%
DP-14.35%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 37.12
P/S N/A
P/FCF 5.35
P/OCF 5.35
P/B 0.41
P/tB 0.41
EV/EBITDA N/A
EPS(TTM)-3.12
EYN/A
EPS(NY)1.95
Fwd EY2.69%
FCF(TTM)13.53
FCFY18.71%
OCF(TTM)13.53
OCFY18.71%
SpS-1.45
BVpS174.97
TBVpS174.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.62%
ROE -1.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM -5096.69%
FCFM -931.13%
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.23%
ROCE(5y)12.24%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
F-Score5
Asset Turnover-0.01
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.25
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.21
Quick Ratio 2.21
Altman-Z 3.75
F-Score5
WACC4.49%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)46.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-104.11%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-104.49%
EPS Next Y-122.68%
EPS Next 2Y-76.12%
EPS Next 3Y-56.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-100.78%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-103.68%
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-102.73%
EBIT growth 3Y69.13%
EBIT growth 5Y9.34%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.71%
FCF growth 3Y-69.35%
FCF growth 5Y-53.45%
OCF growth 1Y-52.81%
OCF growth 3Y-76.44%
OCF growth 5Y-67.23%

EXOR NV / EXO.AS FAQ

What is the ChartMill fundamental rating of EXOR NV (EXO.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to EXO.AS.


What is the valuation status of EXOR NV (EXO.AS) stock?

ChartMill assigns a valuation rating of 2 / 10 to EXOR NV (EXO.AS). This can be considered as Overvalued.


What is the profitability of EXO stock?

EXOR NV (EXO.AS) has a profitability rating of 3 / 10.


Can you provide the financial health for EXO stock?

The financial health rating of EXOR NV (EXO.AS) is 9 / 10.